Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 6

1.

Defining the functional domain of programmed cell death 10 through its interactions with phosphatidylinositol-3,4,5-trisphosphate.

Dibble CF, Horst JA, Malone MH, Park K, Temple B, Cheeseman H, Barbaro JR, Johnson GL, Bencharit S.

PLoS One. 2010 Jul 23;5(7):e11740. doi: 10.1371/journal.pone.0011740.

2.

Cerebral cavernous malformations: from CCM genes to endothelial cell homeostasis.

Fischer A, Zalvide J, Faurobert E, Albiges-Rizo C, Tournier-Lasserve E.

Trends Mol Med. 2013 May;19(5):302-8. doi: 10.1016/j.molmed.2013.02.004. Epub 2013 Mar 15. Review.

PMID:
23506982
3.

Cerebral cavernous malformation proteins at a glance.

Draheim KM, Fisher OS, Boggon TJ, Calderwood DA.

J Cell Sci. 2014 Feb 15;127(Pt 4):701-7. doi: 10.1242/jcs.138388. Epub 2014 Jan 30. Review.

4.

PTEN/PI3K/Akt/VEGF signaling and the cross talk to KRIT1, CCM2, and PDCD10 proteins in cerebral cavernous malformations.

Kar S, Samii A, Bertalanffy H.

Neurosurg Rev. 2015 Apr;38(2):229-36; discussion 236-7. doi: 10.1007/s10143-014-0597-8. Epub 2014 Nov 19. Review.

PMID:
25403688
5.

The CCM3-GCKIII partnership.

Zalvide J, Fidalgo M, Fraile M, Guerrero A, Iglesias C, Floridia E, Pombo CM.

Histol Histopathol. 2013 Oct;28(10):1265-72. doi: 10.14670/HH-28.1265. Epub 2013 Jun 7. Review.

PMID:
23744102
6.

Role of Delta-Notch signaling in cerebral cavernous malformations.

Kar S, Baisantry A, Nabavi A, Bertalanffy H.

Neurosurg Rev. 2016 Oct;39(4):581-9. doi: 10.1007/s10143-015-0699-y. Epub 2016 Jan 16. Review.

PMID:
26779617

Supplemental Content

Support Center